Global Opioid Analgesics Market Size study, by Drug Class, By Indication, By Route of Administration, By End User and Regional Forecasts 2021-2027
発行: Bizwit Research & Consulting LLP
List of figures
Global Opioid Analgesics Market is valued approximately xxx billion in 2020 and is anticipated to grow with a healthy growth rate of more than xxx over the forecast period 2021-2027. Opioids are well known as the most effective drugs for pain management. Their implementation in chronic pain management is a standard procedure in several countries across the world. Growing incidence of cancer, orthopedic diseases, neuropathic pain and chronic pain among the geriatric population serves as key driver for the market. Increasing expenditure on healthcare and increasing disposable income are some other factors driving the Opioid Analgesics Market. Crocin, a medicine which is available in liquid as well as solid form is manufactured by leading analgesics GlaxoSmithKline Asia Private Limited (GSKAP). World Health Organization (WHO) recommends a three-level ladder approach to pain management, which includes the use of drugs with opioid contents. According to Department of Health, about 40% of adults in New York State suffer from a chronic disease and 23% of the state's hospitalization is due to chronic diseases. However, to avoid the chances of addiction and overuse, strict regulations are imposed on sales of opioids which may impede the growth of the market over the forecast period of 2021-2027. Also, the increase in popularity of personalized medicine is likely to increase the market growth during the forecast period.
The regional analysis of global Opioid Analgesics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to increasing chronic illnesses and growing consumption of opioids as a pain medication are expected to continue boosting sales of opioid analgesics. Whereas, Asia-Pacific is also anticipated to exhibit highest CAGR over the forecast period 2021-2027. Factors such as increasing utilization of high amounts of opioids for pain management would create lucrative growth prospects for the Opioid Analgesics Market across Asia-Pacific region.
Major market player included in this report are:
Janssen Pharmaceuticals, Inc. [Johnson & Johnson]
F. Hoffmann-La Roche AG,
Boehringer Ingelheim International GmbH
Bausch Health Companies Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class
By Route of Administration:
By End User:
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027
Target Audience of the Global Opioid Analgesics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers